Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE.
- DOI
- 10.1177/1352458517735190
- Published
- 2018 Dec
- Container
- Multiple sclerosis (Houndmills, Basingstoke, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/1352458517735190,
title = {Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE.},
author = {Cohan S and Kappos L and Giovannoni G and Wiendl H and Selmaj K and Havrdová EK and Rose J and Greenberg S and Phillips G and Ma W and Wang P and Lima G and Sabatella G},
year = {2018},
journal = {Multiple sclerosis (Houndmills, Basingstoke, England)},
doi = {10.1177/1352458517735190},
url = {https://doi.org/10.1177/1352458517735190}
}RIS
TY - JOUR TI - Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE. AU - Cohan S AU - Kappos L AU - Giovannoni G AU - Wiendl H AU - Selmaj K AU - Havrdová EK AU - Rose J AU - Greenberg S AU - Phillips G AU - Ma W AU - Wang P AU - Lima G AU - Sabatella G PY - 2018 JO - Multiple sclerosis (Houndmills, Basingstoke, England) DO - 10.1177/1352458517735190 UR - https://doi.org/10.1177/1352458517735190 ER -
APA
S, C., L, K., G, G., H, W., K, S., EK, H., J, R., S, G., G, P., W, M., P, W., G, L., & G, S. (2018). Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE.. Multiple sclerosis (Houndmills, Basingstoke, England). https://doi.org/10.1177/1352458517735190
Source records
- pubmed · retrieved 2026-09-25T12:14:01.210Z